Global Alzheimer’s Disease Drugs Market and Pipeline Drugs Market Analysis to 2020

1
(No Transcript)
2
Global Alzheimers Disease Drugs Market
Pipeline Drugs Market Analysis to 2020
Alzheimers disease is a devastating condition
for those afflicted as well as their family
members and caregivers the situation is only
getting worse as the population ages. With the
ageing global population, the number of patients
suffering from Alzheimers disease is predicted
to grow during the forecasting period.
Alzheimer's treatment is a high risk, high reward
market. Drugs currently available in the market
have reached maturity patent of leading drugs
have expired. The current unmet needs represent a
huge opportunity for pharmaceutical companies
which are developing targeted novel therapies.
3
Global Alzheimers Disease Drugs Market and
Pipeline Drugs Analysis
In 2014, the global market for Alzheimers
disease drugs was dominated by Namenda and
Exelon. Aricept and Memary stands at the third
and fourth spot respectively in terms of
Alzheimers disease drugs sales in 2014. Ebixa,
Razadyne/Reminyl, Rivastach and Nootropil are the
other popular drugs in the Alzheimers disease
market. With the patent expiration of popular
drugs the sales of the Alzheimers drugs has also
declined. However, there are several pipeline
drugs like Solanezumab, Gantenerumab, Crenezumab
and Lu AE58054 among others which are likely to
hit the market during the period 2017 - 2020.
4
Global Alzheimers Disease Country Wise Analysis
In the Alzheimers disease drugs market, the
United States is the largest market. Japan is the
second leading market for Alzheimers disease
drugs market accounting for XXX market share in
2014. China stands at the third spot in the
global Alzheimers disease drugs market being
followed by India with XXX share in the same
year. The EU5 countries together accounted for
over XXX share of the global Alzheimers disease
drugs market in 2014.
5
Continue (www.igateresearch.com)
iGATE RESEARCH report titled Global Alzheimers
Disease Drugs Market Pipeline Drugs Market
Analysis to 2020 is a 150 page report with 74
Figures and 10 Tables. This report analyses the
Alzheimers Disease Drugs Market, Alzheimers
Disease Pipeline Drugs Market and Clinical Trials
Analysis, Alzheimers Disease - Country Wise
Drugs Market, Country Wise Alzheimers Disease
Prevalence, Major Deals in Alzheimers Disease
Drugs Market Landscape, Funding in Alzheimers
Disease Drugs Research, Driving Factors and
Challenges for Alzheimers Disease Drugs Market.
6
The Alzheimers Disease Drugs Market has been
analyzed from 7 View Points
1. Alzheimers Disease - Drugs Sales and Forecast
2. Alzheimers Disease - Pipeline Drugs Sales
Forecast 3. Alzheimers Disease Drugs - Country
Wise Market and Forecast 4. Alzheimers Disease -
Country Wise Prevalence and Forecast 5.
Alzheimers Disease - Pipeline Drugs Clinical
Trials Analysis 6. Alzheimers Disease - Major
Deals in Alzheimers Drugs Market 7. Alzheimers
Disease - Funding in Alzheimers Disease Research
7
The Top 9 Alzheimers Disease Drugs covered in
the report are as follows
1. Exelon 2. Razadyne/Reminyl 3. Memary 4.
Ebixa 5. Aricept 6. Rivastach 7. Namenda 8.
Nootropil 9. Namzaric
8
The 7 Pipeline Alzheimers Disease Drugs covered
in the report are as follows
1. Solanezumab 2. ABT-126 3. idalopirdine 4.
Gantenerumab 5. Crenezumab 6. Lu AE58054 7.
BIIB037
9
The 9 Countries Alzheimers Disease Drugs Market
covered in the report are as follows
1. United States 2. France 3. Germany 4. Italy 5.
Spain 6. United Kingdom 7. Japan 8. China 9.
India
10
The Alzheimers Disease Drugs Major Deals covered
in the report are as follows
1. Strategic Alliance 2. Licensing Agreement 3.
Collaboration Deals 4. Mergers and Acquisitions
11
Source of Information
iGATE RESEARCH employs rigorous primary and
secondary research techniques in developing
distinctive data sets and research material for
business reports. This report is built by using
data and information sourced from Proprietary
Information Database, Primary and Secondary
Research Methodologies, and In house analysis by
iGATE Research dedicated team of qualified
professionals with deep industry experience and
expertise.
12
Published By
iGATE RESEARCH Phone [phone]
(India) 91-706-527-9335 (India)
Email info_at_igateresearch.com Internet
www.igateresearch.com          
13
Format
Report Title Global Alzheimers Disease Drugs
Market and Pipeline Drugs Market Analysis to
2020 To Order the Report Visit
http//www.igateresearch.com/ProductDetail.php?p
d_nameGlobal20Alzheimers20Disease20Drugs20Mar
ket20Analysis
Single User License US 1,100
Hard-copy Mail Delivery US 1,250
CD-ROM Mail Delivery US 1,200
Multi User License US 1,600

14
Order the Report
iGATE RESEARCH PVT. LTD. Web www.igateresearch.c
om To order the Report E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA) For
Report Related Query E-Mail 
info_at_igateresearch.com Contact No.
91-858-684-0791, 91-706-527-9335 (INDIA)